基本信息
浏览量:6
职业迁徙
个人简介
Research Summary
Dr Qasim Rafiq is an Associate Professor at University College London in Cell and Gene Therapy Bioprocess Engineering. He is a multidisciplinary engineer working at the life science, engineering and commercial interfaces with a research focus on the bioprocessing, automation and biomanufacture of cell and gene-based therapies. Product applications include stem cells (mesenchymal, haematopoietic and pluripotent), extracellular vesicles and gene-modified T-cells. He has specific interest in addressing the large-scale manufacturing challenges and enhancing process and product understanding to enable successful translation from the laboratory to the clinic.
Qasim currently leads a research portfolio of >£5M as Principal Investigator and >£20M as Co-Investigator and leads the Cell and Gene Therapy Bioprocess Engineering group at UCL which includes 4 post-doctoral researchers and 11 PhD students. He has collaborated with >25 industrial and clinical partners and has an extensive track record of clinical and commercial delivery.
He is Programme Director of a new MSc programme at UCL in “Manufacture and Commercialisation of Stem Cell and Gene Therapies” and is actively involved in national and international training programmes to deliver the scientific, technology and business leaders that will drive the industry forward.
Prior to joining UCL, he was an Assistant Professor at Aston University where he established the Bioprocess Engineering Group. He completed his PhD in Regenerative Medicine Bioprocessing at Loughborough University (UK) in collaboration with Lonza, a leading biotechnology contract manufacturing organisation, where he was the first to demonstrate the litre-scale production of hMSCs on microcarriers in stirred-tank bioreactors.
He has won awards for his research and public engagement activities and in 2020 was recognised as one of the top 20 influential and inspirational individuals in Advanced Medicine by The Medicine Maker listed amongst Nobel Laureates, multi-national CEOs and leading scientists.
Dr Qasim Rafiq is an Associate Professor at University College London in Cell and Gene Therapy Bioprocess Engineering. He is a multidisciplinary engineer working at the life science, engineering and commercial interfaces with a research focus on the bioprocessing, automation and biomanufacture of cell and gene-based therapies. Product applications include stem cells (mesenchymal, haematopoietic and pluripotent), extracellular vesicles and gene-modified T-cells. He has specific interest in addressing the large-scale manufacturing challenges and enhancing process and product understanding to enable successful translation from the laboratory to the clinic.
Qasim currently leads a research portfolio of >£5M as Principal Investigator and >£20M as Co-Investigator and leads the Cell and Gene Therapy Bioprocess Engineering group at UCL which includes 4 post-doctoral researchers and 11 PhD students. He has collaborated with >25 industrial and clinical partners and has an extensive track record of clinical and commercial delivery.
He is Programme Director of a new MSc programme at UCL in “Manufacture and Commercialisation of Stem Cell and Gene Therapies” and is actively involved in national and international training programmes to deliver the scientific, technology and business leaders that will drive the industry forward.
Prior to joining UCL, he was an Assistant Professor at Aston University where he established the Bioprocess Engineering Group. He completed his PhD in Regenerative Medicine Bioprocessing at Loughborough University (UK) in collaboration with Lonza, a leading biotechnology contract manufacturing organisation, where he was the first to demonstrate the litre-scale production of hMSCs on microcarriers in stirred-tank bioreactors.
He has won awards for his research and public engagement activities and in 2020 was recognised as one of the top 20 influential and inspirational individuals in Advanced Medicine by The Medicine Maker listed amongst Nobel Laureates, multi-national CEOs and leading scientists.
研究兴趣
论文共 80 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Tiffany Hood, Fern Slingsby, Viktor Sandner, Winfried Geis, Timo Schmidberger,Nicola Bevan, Quentin Vicard, Julia Hengst, Pierre Springuel, Noushin Dianat,Qasim A. Rafiq
Dale J. Stibbs,Pedro Silva Couto,Yasuhiro Takeuchi,Qasim A. Rafiq, Nigel B. Jackson,Andrea C. M. E. Rayat
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENTno. 1 (2024): 1-11
Dale J. Stibbs,Pedro Silva Couto,Yasuhiro Takeuchi,Qasim A. Rafiq, Nigel B. Jackson,Andrea C.M. E. Rayat
Molecular Therapy - Methods & Clinical Developmentno. 2 (2024): 101264
John J. L. Jacobs, Inés Beekers, Inge Verkouter, Levi B. Richards, Alexandra Vegelien, Lizan D. Bloemsma, Vera A. M. C. Bongaerts,Jacqueline Cloos, Frederik Erkens,Patrycja Gradowska,Simon Hort, Michael Hudecek,
medrxiv(2024)
Pedro Silva Couto, Dale J. Stibbs, Marco C. Rotondi, Rana Khalife, Dennis Wolf,Yasuhiro Takeuchi,Qasim A. Rafiq
Cytotherapy (2024)
David F. Nettleton, Nuria Mari-Buye, Helena Marti-Soler,Joseph R. Egan,Simon Hort, David Horna, Miquel Costa, Elia Vallejo Benitez-Cano,Stephen Goldrick,Qasim A. Rafiq,Niels Koenig,Robert H. Schmitt,
SENSORSno. 24 (2023): 9676
Applied microbiology and biotechnologyno. 18 (2023): 5669-5685
Pedro Silva Couto, Samuel A. Molina,Denis O’Sullivan,Liam O’Neill, Alexander M. Lyness,Qasim A. Rafiq
Molecular therapy. Methods & clinical development (2023): 221-234
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn